[{"Assets_0_Q2_USD":165640000.0,"CommonStockSharesOutstanding_0_Q2_shares":62376416.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-73158000.0,"NetIncomeLoss_2_Q2_USD":-82086000.0,"NetIncomeLoss_1_Q2_USD":-44672000.0,"StockholdersEquity_0_Q2_USD":83445000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":62126000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":62209000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":62126000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":62209000.0,"Ticker":"INSM","CIK":"1104506","name":"INSMED INC","OfficialName":"Insmed Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2980602494.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170803"}]